{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:50:10Z","timestamp":1792345810483,"version":"4.4.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T00:00:00Z","timestamp":1423094400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s12265-015-9612-x","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T14:44:34Z","timestamp":1423061074000},"page":"106-116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cardiac Allograft Vasculopathy: A Donor or Recipient Induced Pathology?"],"prefix":"10.1007","volume":"8","author":[{"given":"Patricia","family":"van den Hoogen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon M. H.","family":"Huibers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P. G.","family":"Sluijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel A.","family":"de Weger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,5]]},"reference":[{"key":"9612_CR1","first-page":"10","volume":"78229","author":"D Behrendt","year":"2000","unstructured":"Behrendt, D., Ganz, P., & Fang, J. (2000). Cardiac allograft vasculopathy. Current Opinion in Cardiology, 78229, 10\u201316.","journal-title":"Current Opinion in Cardiology"},{"key":"9612_CR2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.healun.2013.08.006","volume":"32","author":"LH Lund","year":"2013","unstructured":"Lund, L. H., Edwards, L. B., Kucheryavaya, A. Y., et al. (2013). The registry of the international society for heart and lung transplantation: thirtieth official adult heart transplant report\u20132013; focus theme: age. Journal of Heart and Lung Transplantation, 32, 951\u2013964. doi: 10.1016\/j.healun.2013.08.006 .","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"9612_CR3","author":"A Seki","year":"2014","unstructured":"Seki, A., & Fishbein, M. C. (2014). Predicting the development of cardiac allograft vasculopathy. Cardiovascular Pathology. doi: 10.1016\/j.carpath.2014.05.001 .","journal-title":"Cardiovascular Pathology"},{"key":"9612_CR4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1517\/14728222.2012.697555","volume":"16","author":"J Suzuki","year":"2012","unstructured":"Suzuki, J., Ogawa, M., Hirata, Y., et al. (2012). Effects of immunoglobulin to prevent coronary allograft vasculopathy in heart transplantation. Expert Opinion on Therapeutic Targets, 16, 783\u2013789. doi: 10.1517\/14728222.2012.697555 .","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"9612_CR5","first-page":"395","volume":"40","author":"J Costello","year":"2013","unstructured":"Costello, J. (2013). Mechanisms of chronic cardiac allograft rejection. Texas Heart Instrum, 40, 395\u2013399.","journal-title":"Texas Heart Instrum"},{"key":"9612_CR6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/CVM-1-3-166","volume":"1","author":"J Kobashigawa","year":"2000","unstructured":"Kobashigawa, J. (2000). What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy? Current Controlled Trials in Cardiovascular Medicine, 1, 166\u2013171. doi: 10.1186\/cvm-1-3-166 .","journal-title":"Current Controlled Trials in Cardiovascular Medicine"},{"key":"9612_CR7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.healun.2012.09.030","volume":"32","author":"KP Daly","year":"2013","unstructured":"Daly, K. P., Seifert, M. E., Chandraker, A., et al. (2013). VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients. Journal of Heart and Lung Transplantation, 32, 120\u2013128. doi: 10.1016\/j.healun.2012.09.030 .","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"9612_CR8","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.healun.2011.04.008","volume":"30","author":"W Lu","year":"2011","unstructured":"Lu, W., Palatnik, K., Fishbein, G. A., et al. (2011). Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts. Journal of Heart and Lung Transplantation, 30, 1044\u20131050. 10.1016\/j.healun.2011.04.008.","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"9612_CR9","doi-asserted-by":"crossref","unstructured":"Pober, J.S., Jane-Wit, D., Qin, L., Tellides, G. (2014). Interacting Mechanisms in the Pathogenesis of Cardiac Allograft Vasculopathy. Arterioscler Thromb Vasc Biol. 1609\u20131614. doi: 10.1161\/ATVBAHA.114.302818.","DOI":"10.1161\/ATVBAHA.114.302818"},{"key":"9612_CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.pathol.3.121806.151449","volume":"4","author":"RN Mitchell","year":"2009","unstructured":"Mitchell, R. N. (2009). Graft vascular disease: immune response meets the vessel wall. Annual Review of Pathology, 4, 19\u201347. doi: 10.1146\/annurev.pathol.3.121806.151449 .","journal-title":"Annual Review of Pathology"},{"key":"9612_CR11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.4049\/jimmunol.1004195","volume":"187","author":"S Kalache","year":"2011","unstructured":"Kalache, S., Dinavahi, R., Pinney, S., Mehrotra, A., Madeleine, W., & Cunningham, P. S. H. (2011). Anti-cardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients. Journal of Immunology, 187, 1023\u20131030. doi: 10.4049\/jimmunol.1004195.Anti-cardiac .","journal-title":"Journal of Immunology"},{"key":"9612_CR12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2014.07.016","volume":"236","author":"MMH Huibers","year":"2014","unstructured":"Huibers, M. M. H., Vink, A., Kaldeway, J., et al. (2014). Distinct phenotypes of cardiac allograft vasculopathy after heart transplantation: a histopathological study. Atherosclerosis, 236, 353\u2013359. doi: 10.1016\/j.atherosclerosis.2014.07.016 .","journal-title":"Atherosclerosis"},{"key":"9612_CR13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1053-2498(03)00222-5","volume":"23","author":"C Atkinson","year":"2004","unstructured":"Atkinson, C., Horsley, J., Rhind-Tutt, S., et al. (2004). Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin. Journal of Heart and Lung Transplantation, 23, 427\u2013435. doi: 10.1016\/S1053-2498(03)00222-5 .","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"9612_CR14","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/hep.22161","volume":"47","author":"H Ueta","year":"2008","unstructured":"Ueta, H., Shi, C., Miyanari, N., et al. (2008). Systemic transmigration of allosensitizing donor dendritic cells to host secondary lymphoid organs after rat liver transplantation. Hepatology, 47, 1352\u20131362. doi: 10.1002\/hep.22161 .","journal-title":"Hepatology"},{"key":"9612_CR15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11936-013-0278-x","volume":"16","author":"RD Benatti","year":"2014","unstructured":"Benatti, R. D., & Taylor, D. O. (2014). Evolving concepts and treatment strategies for cardiac allograft vasculopathy. Current Treatment Options Cardiovascular Medical, 16, 278. doi: 10.1007\/s11936-013-0278-x .","journal-title":"Current Treatment Options Cardiovascular Medical"},{"key":"9612_CR16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/01.CIR.0000081703.34526.5D","volume":"108","author":"D Simper","year":"2003","unstructured":"Simper, D., Wang, S., Deb, A., et al. (2003). Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation, 108, 143\u2013149. doi: 10.1161\/01.CIR.0000081703.34526.5D .","journal-title":"Circulation"},{"key":"9612_CR17","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/thx.2008.104133","volume":"64","author":"LA Borthwick","year":"2009","unstructured":"Borthwick, L. A., Parker, S. M., Brougham, K. A., et al. (2009). Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. Thorax, 64, 770\u2013777. doi: 10.1136\/thx.2008.104133 .","journal-title":"Thorax"},{"key":"9612_CR18","first-page":"174","volume":"8","author":"H Eisen","year":"2008","unstructured":"Eisen, H. (2008). Heart transplantation: graft rejection basics. Johns Hopkins Advanced Studies in Medieval, 8, 174\u2013181.","journal-title":"Johns Hopkins Advanced Studies in Medieval"},{"key":"9612_CR19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12265-012-9414-3","volume":"6","author":"M Colvin-Adams","year":"2013","unstructured":"Colvin-Adams, M., Harcourt, N., & Duprez, D. (2013). Endothelial dysfunction and cardiac allograft vasculopathy. Journal of Cardiovascular Translational Research, 6, 263\u2013277. doi: 10.1007\/s12265-012-9414-3 .","journal-title":"Journal of Cardiovascular Translational Research"},{"key":"9612_CR20","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.4049\/jimmunol.181.5.3212","volume":"181","author":"LA Smyth","year":"2008","unstructured":"Smyth, L. A., Harker, N., Turnbull, W., et al. (2008). The relative efficiency of acquisition of MHC:peptide complexes and cross-presentation depends on dendritic cell type. Journal of Immunology, 181, 3212\u20133220. doi: 10.4049\/jimmunol.181.5.3212 .","journal-title":"Journal of Immunology"},{"key":"9612_CR21","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4049\/jimmunol.176.3.1447","volume":"176","author":"BP Dolan","year":"2006","unstructured":"Dolan, B. P., Gibbs, K. D., & Ostrand-Rosenberg, S. (2006). Tumor-specific CD4+ T cells are activated by \u201ccross-dressed\u201d dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. Journal of Immunology, 176, 1447\u20131455. doi: 10.4049\/jimmunol.176.3.1447 .","journal-title":"Journal of Immunology"},{"key":"9612_CR22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00000658-199904000-00018","volume":"229","author":"ND Jones","year":"1999","unstructured":"Jones, N. D., Van Maurik, A., Hara, M., et al. (1999). T-cell activation, proliferation, and memory after cardiac transplantation in vivo. Annals of Surgery, 229, 570\u2013578.","journal-title":"Annals of Surgery"},{"key":"9612_CR23","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/TP.0b013e3182157d60","volume":"91","author":"Q Zhang","year":"2011","unstructured":"Zhang, Q., Cecka, J., Gjertson, D., & Ge, P. (2011). HLA and MICA: targets of antibody-mediated rejection in heart transplantation. Transplantation, 91, 1153\u20131158. doi: 10.1097\/TP.0b013e3182157d60 . HLA.","journal-title":"Transplantation"},{"key":"9612_CR24","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.humimm.2013.07.002","volume":"74","author":"N Angaswamy","year":"2013","unstructured":"Angaswamy, N., Tiriveedhi, V., Sarma, N. J., et al. (2013). Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection. Human Immunology, 74, 1478\u20131485. doi: 10.1016\/j.humimm.2013.07.002 .","journal-title":"Human Immunology"},{"key":"9612_CR25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOT.0b013e3283342780","volume":"15","author":"D Nath","year":"2010","unstructured":"Nath, D., Basha, H., & Mohanakumar, T. (2010). Anti-human leukocyte antigen antibody induced autoimmunity: role in chronic rejection. Current Opin Organic, 15, 16\u201320. doi: 10.1097\/MOT.0b013e3283342780 . Anti-Human.","journal-title":"Current Opin Organic"},{"key":"9612_CR26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MOT.0b013e32832fb981","volume":"14","author":"RR Hachem","year":"2009","unstructured":"Hachem, R. R. (2009). Lung allograft rejection: diagnosis and management. Current Opinion in Organ Transplantation, 14, 477\u2013482. doi: 10.1097\/MOT.0b013e32832fb981 .","journal-title":"Current Opinion in Organ Transplantation"},{"key":"9612_CR27","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.2741\/2393","volume":"12","author":"G Benichou","year":"2007","unstructured":"Benichou, G., Alessandrini, A., & Rachida-Sihem Charrad, D. S. W. (2007). Induction of autoimmunity after allotransplantation. Frontiers in Bioscience, 12, 4362\u20134369.","journal-title":"Frontiers in Bioscience"},{"key":"9612_CR28","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00007890-200210150-00028","volume":"74","author":"HK Rolls","year":"2002","unstructured":"Rolls, H. K., Kishimoto, K., Dong, V. M., et al. (2002). T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection. Transplantation, 74, 1053\u20131057.","journal-title":"Transplantation"},{"key":"9612_CR29","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.2741\/2903","volume":"13","author":"MJ Weiss","year":"2008","unstructured":"Weiss, M. J., Madsen, J. C., Rosengard, B. R., & Allan, J. S. (2008). Mechanisms of chronic rejection in cardiothoracic transplantation. Frontiers in Bioscience, 13, 2980\u20132988.","journal-title":"Frontiers in Bioscience"},{"key":"9612_CR30","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.4049\/jimmunol.169.3.1168","volume":"169","author":"EV Fedoseyeva","year":"2002","unstructured":"Fedoseyeva, E. V., Kishimoto, K., Rolls, H. K., et al. (2002). Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants. Journal of Immunology, 169, 1168\u20131174. doi: 10.4049\/jimmunol.169.3.1168 .","journal-title":"Journal of Immunology"},{"key":"9612_CR31","first-page":"1191","volume":"71","author":"D Nath","year":"2010","unstructured":"Nath, D., Angaswamy, N., & Basha, H. (2010). With and precede antibodies to MICA in antibody mediated rejection and cardiac allograft vasculopathy following human cardiac transplantation. Humain, 71, 1191\u20131196. doi: 10.1016\/j.humimm.2010.09.012 . Donor.","journal-title":"Humain"},{"key":"9612_CR32","doi-asserted-by":"crossref","first-page":"s32","DOI":"10.1086\/320902","volume":"33","author":"W Bij Van Der","year":"2001","unstructured":"Van Der Bij, W., & Speich, R. (2001). Management of cytomegalovirus infection and disease after solid-organ transplantation. Clinical Infectious Diseases, 33, s32\u2013s37.","journal-title":"Clinical Infectious Diseases"},{"key":"9612_CR33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/QCO.0b013e328259c33b","volume":"20","author":"L Potena","year":"2007","unstructured":"Potena, L., & Valantine, H. A. (2007). Cytomegalovirus-associated allograft rejection in heart transplant patients. Current Opinion in Infectious Diseases, 20, 425\u2013431.","journal-title":"Current Opinion in Infectious Diseases"},{"key":"9612_CR34","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1681\/ASN.2006111261","volume":"18","author":"A Izawa","year":"2007","unstructured":"Izawa, A., Ueno, T., Jurewicz, M., et al. (2007). Importance of donor- and recipient-derived selectins in cardiac allograft rejection. Journal of the American Society of Nephrology, 18, 2929\u20132936. doi: 10.1681\/ASN.2006111261 .","journal-title":"Journal of the American Society of Nephrology"},{"key":"9612_CR35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1189\/jlb.69.5.705","volume":"69","author":"T Saiki","year":"2001","unstructured":"Saiki, T., Ezaki, T., & Ogawa, M. (2001). In vivo roles of donor and host dendritic cells in allogeneic immune response: cluster formation with host proliferating T cells. Journal of Leukocyte, 69, 705\u2013712.","journal-title":"Journal of Leukocyte"},{"key":"9612_CR36","first-page":"25","volume":"1","author":"P Halloran","year":"1998","unstructured":"Halloran, P. (1998). Non-immunologic tissue injury and stress in chronic allograft dysfunction. Graft, 1, 25\u201329.","journal-title":"Graft"},{"key":"9612_CR37","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0952-7915(02)00386-2","volume":"14","author":"S Gourishankar","year":"2002","unstructured":"Gourishankar, S., & Halloran, P. F. (2002). Late deterioration of organ transplants: a problem in injury and homeostasis. Current Opinion in Immunology, 14, 576\u2013583. doi: 10.1016\/S0952-7915(02)00386-2 .","journal-title":"Current Opinion in Immunology"},{"key":"9612_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/521369","volume":"2013","author":"RP Watts","year":"2013","unstructured":"Watts, R. P., Thom, O., & Fraser, J. F. (2013). Inflammatory signalling associated with brain dead organ donation: from brain injury to brain stem death and posttransplant ischaemia reperfusion injury organ injury: current concepts. Journal of Transplantation, 2013, 1\u201319.","journal-title":"Journal of Transplantation"},{"key":"9612_CR39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.ASN.0000042164.03115.B8","volume":"14","author":"S Gourishankar","year":"2003","unstructured":"Gourishankar, S. (2003). Donor tissue characteristics influence cadaver kidney transplant function and graft survival but not rejection. Journal of the American Society of Nephrology, 14, 493\u2013499. doi: 10.1097\/01.ASN.0000042164.03115.B8 .","journal-title":"Journal of the American Society of Nephrology"},{"key":"9612_CR40","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1161\/hc5001.100796","volume":"104","author":"SM Hollenberg","year":"2015","unstructured":"Hollenberg, S. M., Klein, L. W., Parrillo, J. E., et al. (2015). Coronary endothelial dysfunction after heart cardiac death. Circulation, 104, 3091\u20133097.","journal-title":"Circulation"},{"key":"9612_CR41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1681\/ASN.2008040377","volume":"20","author":"T Ueno","year":"2009","unstructured":"Ueno, T., Tanaka, K., Jurewicz, M., et al. (2009). Divergent role of donor dendritic cells in rejection versus tolerance of allografts. Journal of the American Society of Nephrology, 20, 535\u2013544. doi: 10.1681\/ASN.2008040377 .","journal-title":"Journal of the American Society of Nephrology"},{"key":"9612_CR42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/CIRCHEARTFAILURE.108.827139","volume":"2","author":"TS Win","year":"2009","unstructured":"Win, T. S., Rehakova, S., Negus, M. C., et al. (2009). Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production. Circulation Heart Failure, 2, 361\u2013369. doi: 10.1161\/CIRCHEARTFAILURE.108.827139 .","journal-title":"Circulation Heart Failure"},{"key":"9612_CR43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.171.1.307","volume":"171","author":"C Larsen","year":"1990","unstructured":"Larsen, C., Morris, P., & Austyn, J. (1990). Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. Journal of Experimental, 171, 307\u2013314.","journal-title":"Journal of Experimental"},{"key":"9612_CR44","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0140-6736(92)91840-5","volume":"339","author":"T Starzl","year":"1992","unstructured":"Starzl, T., Murase, N., Ildstad, S., & Ricordi, C. (1992). Cell migration, chimerism, and graft acceptance. Lancet, 339, 1579\u20131582.","journal-title":"Lancet"},{"key":"9612_CR45","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/CIRCULATIONAHA.107.741025","volume":"117","author":"J Yang","year":"2008","unstructured":"Yang, J., Popoola, J., Khandwala, S., et al. (2008). Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. Circulation, 117, 660\u2013669. doi: 10.1161\/CIRCULATIONAHA.107.741025 .","journal-title":"Circulation"},{"key":"9612_CR46","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.4049\/jimmunol.179.8.5204","volume":"179","author":"K Tanaka","year":"2007","unstructured":"Tanaka, K., Albin, M. J., Yuan, X., et al. (2007). PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection. Journal of Immunology, 179, 5204\u20135210. doi: 10.4049\/jimmunol.179.8.5204 .","journal-title":"Journal of Immunology"},{"key":"9612_CR47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/01.CIR.95.1.191","volume":"95","author":"PK Koskinen","year":"1997","unstructured":"Koskinen, P. K., & Lemstro, K. B. (1997). Adhesion molecule P-selectin and vascular cell adhesion molecule\u20131 in enhanced heart allograft arteriosclerosis in the rat. Circulation, 95, 191\u2013196.","journal-title":"Circulation"},{"key":"9612_CR48","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1378\/chest.110.5.1143","volume":"110","author":"R Shreeniwas","year":"1996","unstructured":"Shreeniwas, R. (1996). Adhesion molecules (E-selectin and ICAM-1) in pulmonary allograft rejection. CHEST, 110, 1143\u20131149.","journal-title":"CHEST"},{"key":"9612_CR49","author":"B Sarraj","year":"2014","unstructured":"Sarraj, B., Ye, J., Akl, A. I., et al. (2014). Impaired selectin-dependent leukocyte recruitment induces T-cell exhaustion and prevents chronic allograft vasculopathy and rejection. Proceedings of the National Academy of Sciences of the United States of America. doi: 10.1073\/pnas.1303676111 .","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9612_CR50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.healun.2012.02.005","volume":"31","author":"KK Khush","year":"2012","unstructured":"Khush, K. K., Kubo, J. T., & Desai, M. (2012). Influence of donor and recipient sex mismatch on heart transplant outcomes: analysis of the international society for heart and lung transplantation registry. Journal of Heart and Lung Transplantation, 31, 459\u2013466. doi: 10.1016\/j.healun.2012.02.005 .","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"9612_CR51","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/S0041-1345(99)00818-0","volume":"31","author":"B Schlechta","year":"1999","unstructured":"Schlechta, B., Kocher, A. A., Ofner, P., et al. (1999). Impact of gender mismatch on the outcome of heart transplantation. Transplantation Proceedings, 31, 3340\u20133342.","journal-title":"Transplantation Proceedings"},{"key":"9612_CR52","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1053-2498(00)00116-9","volume":"19","author":"MR Mehra","year":"2000","unstructured":"Mehra, M. R. (2000). Crossing the vasculopathy bridge from morphology to therapy: a single center experience. Journal of Heart and Lung Transplantation, 19, 522\u2013528.","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"9612_CR53","first-page":"73","volume":"2","author":"RM Reed","year":"2014","unstructured":"Reed, R. M., Netzer, G., Hunsicker, L., Mitchell, B. D., Rajagopal, K., & Scharf, S. E. M. (2014). Cardiac size and sex-matching in heart transplantation: size matters in matters of sex and the heart. American Collegium Cardiology Foundations Heart Failure, 2, 73\u201383.","journal-title":"American Collegium Cardiology Foundations Heart Failure"},{"key":"9612_CR54","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1097\/01.ASN.0000030078.74889.69","volume":"13","author":"M Zeier","year":"2002","unstructured":"Zeier, M. (2002). The effect of donor gender on graft survival. Journal of the American Society of Nephrology, 13, 2570\u20132576. doi: 10.1097\/01.ASN.0000030078.74889.69 .","journal-title":"Journal of the American Society of Nephrology"},{"key":"9612_CR55","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.transproceed.2009.06.098","volume":"41","author":"H Welp","year":"2009","unstructured":"Welp, H., Spieker, T., Erren, M., et al. (2009). Sex mismatch in heart transplantation is associated with increased number of severe rejection episodes and shorter long-term survival. Transplantation Proceedings, 41, 2579\u20132584.","journal-title":"Transplantation Proceedings"},{"key":"9612_CR56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/TP.0b013e31817352b9","volume":"86","author":"J Tan","year":"2008","unstructured":"Tan, J., Wadia, P., & Coram, M. (2008). HY antibody development associates with acute rejection in female patients with male kidney transplants. Transplantation, 86, 75\u201381. doi: 10.1097\/TP.0b013e31817352b9.H-Y .","journal-title":"Transplantation"},{"key":"9612_CR57","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.trim.2011.07.001","volume":"25","author":"M Huibers","year":"2011","unstructured":"Huibers, M., De Jonge, N., Van Kuik, J., et al. (2011). Intimal fibrosis in human cardiac allograft vasculopathy. Transplant Immunology, 25, 124\u2013132. doi: 10.1016\/j.trim.2011.07.001 .","journal-title":"Transplant Immunology"},{"key":"9612_CR58","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.RES.0000246086.93555.f3","volume":"99","author":"M Rahmani","year":"2006","unstructured":"Rahmani, M., Cruz, R. P., Granville, D. J., & McManus, B. M. (2006). Allograft vasculopathy versus atherosclerosis. Circulation Research, 99, 801\u2013815. doi: 10.1161\/01.RES.0000246086.93555.f3 .","journal-title":"Circulation Research"},{"key":"9612_CR59","author":"Q Zeng","year":"2014","unstructured":"Zeng, Q., Ng, Y., Singh, T., et al. (2014). B cells mediate chronic allograft rejection independently of antibody production. Journal. doi: 10.1172\/JCI70084DS1 .","journal-title":"Journal"},{"key":"9612_CR60","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/j.healun.2006.11.255","volume":"26","author":"E Koning de","year":"2007","unstructured":"de Koning, E., van Kuik, J., van Wichen, D. F., et al. (2007). 237: M2 macrophages: keyplayers in the fibro-proliferative response in cardiac allograft vasculopathy. Journal Heart Lung Transplantation, 26, S145.","journal-title":"Journal Heart Lung Transplantation"},{"key":"9612_CR61","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1111\/j.1600-6143.2007.01997.x","volume":"7","author":"WH Kitchens","year":"2007","unstructured":"Kitchens, W. H., Chase, C. M., Uehara, S., et al. (2007). Macrophage depletion suppresses cardiac allograft vasculopathy in mice. American Journal of Transplantation, 7, 2675\u20132682. doi: 10.1111\/j.1600-6143.2007.01997.x .","journal-title":"American Journal of Transplantation"},{"key":"9612_CR62","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani, A., Sica, A., Sozzani, S., et al. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology, 25, 677\u2013686. doi: 10.1016\/j.it.2004.09.015 .","journal-title":"Trends in Immunology"},{"key":"9612_CR63","first-page":"5","volume":"346","author":"F Quaini","year":"2002","unstructured":"Quaini, F., & Urbanek, K. (2002). Chimerism of the transplanted heart. English Journal, 346, 5\u201315.","journal-title":"English Journal"},{"key":"9612_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2004.10.002","volume":"15","author":"J-L Hillebrands","year":"2005","unstructured":"Hillebrands, J.-L., Onuta, G., & Rozing, J. (2005). Role of progenitor cells in transplant arteriosclerosis. Trends in Cardiovascular Medicine, 15, 1\u20138. doi: 10.1016\/j.tcm.2004.10.002 .","journal-title":"Trends in Cardiovascular Medicine"},{"key":"9612_CR65","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.ATV.0000059337.60393.64","volume":"23","author":"J-L Hillebrands","year":"2003","unstructured":"Hillebrands, J.-L., Klatter, F. A., & Rozing, J. (2003). Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 380\u2013387. doi: 10.1161\/01.ATV.0000059337.60393.64 .","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"9612_CR66","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCRESAHA.109.207266","volume":"105","author":"DA D\u2019Alessandro","year":"2009","unstructured":"D\u2019Alessandro, D. A., Kajstura, J., Hosoda, T., et al. (2009). Progenitor cells from the explanted heart generate immunocompatible myocardium within the transplanted donor heart. Circulation Research, 105, 1128\u20131140. doi: 10.1161\/CIRCRESAHA.109.207266 .","journal-title":"Circulation Research"},{"key":"9612_CR67","first-page":"593","volume":"348","author":"J Hill","year":"2003","unstructured":"Hill, J., & Zalos, G. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. English Journal, 348, 593\u2013600.","journal-title":"English Journal"},{"key":"9612_CR68","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1432-2277.2009.01043.x","volume":"23","author":"CJ Sathya","year":"2010","unstructured":"Sathya, C. J., Sheshgiri, R., Prodger, J., et al. (2010). Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients. Transplant International, 23, 641\u2013648. doi: 10.1111\/j.1432-2277.2009.01043.x .","journal-title":"Transplant International"},{"key":"9612_CR69","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1161\/CIRCULATIONAHA.105.576017","volume":"112","author":"E Minami","year":"2005","unstructured":"Minami, E., Laflamme, M. A., Saffitz, J. E., & Murry, C. E. (2005). Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation, 112, 2951\u20132958. doi: 10.1161\/CIRCULATIONAHA.105.576017 .","journal-title":"Circulation"},{"key":"9612_CR70","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/01.TP.0000048488.35010.95","volume":"75","author":"GD Wu","year":"2003","unstructured":"Wu, G. D., Nolta, J. A., Jin, Y. S., et al. (2003). Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation, 75, 679. 95.","journal-title":"Transplantation"},{"key":"9612_CR71","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1309\/GAFN-5MPA-LY8E-DTPQ","volume":"115","author":"I Bittmann","year":"2001","unstructured":"Bittmann, I., Dose, T., Baretton, G. B., et al. (2001). Cellular chimerism of the lung after transplantation. An interphase cytogenetic study. American Journal of Clinical Pathology, 115, 525\u2013533. doi: 10.1309\/GAFN-5MPA-LY8E-DTPQ .","journal-title":"American Journal of Clinical Pathology"},{"key":"9612_CR72","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.bmt.1705939","volume":"41","author":"RA Weger De","year":"2008","unstructured":"De Weger, R. A., Verbrugge, I., Bruggink, A. H., et al. (2008). Stem cell-derived cardiomyocytes after bone marrow and heart transplantation. Bone Marrow Transplantation, 41, 563\u2013569. doi: 10.1038\/sj.bmt.1705939 .","journal-title":"Bone Marrow Transplantation"},{"key":"9612_CR73","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/01.TP.0000066362.37931.6D","volume":"76","author":"GD Wu","year":"2003","unstructured":"Wu, G. D., Tuan, T.-L., Bowdish, M. E., et al. (2003). Evidence for recipient derived fibroblast recruitment and activation during the development of chronic cardiac allograft rejection. Transplantation, 76, 609\u2013614. doi: 10.1097\/01.TP.0000066362.37931.6D .","journal-title":"Transplantation"},{"key":"9612_CR74","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jacc.2011.11.036","volume":"59","author":"M Pichler","year":"2012","unstructured":"Pichler, M., Rainer, P. P., Schauer, S., & Hoefler, G. (2012). Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac origin. Journal of the American College of Cardiology, 59, 1008\u20131016. doi: 10.1016\/j.jacc.2011.11.036 .","journal-title":"Journal of the American College of Cardiology"},{"key":"9612_CR75","first-page":"791","volume":"4","author":"R Salomon","year":"1991","unstructured":"Salomon, R., & Hughes, C. (1991). Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. The American Journal, 4, 791\u2013798.","journal-title":"The American Journal"},{"key":"9612_CR76","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.celrep.2012.10.021","volume":"2","author":"P Chen","year":"2012","unstructured":"Chen, P., Qin, L., Barnes, C., et al. (2012). FGF regulates TGF-\u03b2 signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell Reports, 2, 1684\u20131696. doi: 10.1016\/j.celrep.2012.10.021.FGF .","journal-title":"Cell Reports"},{"key":"9612_CR77","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.111.040352","volume":"125","author":"JC Kovacic","year":"2012","unstructured":"Kovacic, J. C., Mercader, N., Torres, M., et al. (2012). Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease. Circulation, 125, 1795\u20131808.","journal-title":"Circulation"},{"key":"9612_CR78","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1161\/CIRCRESAHA.111.259960","volume":"110","author":"A Gise von","year":"2012","unstructured":"von Gise, A., & Pu, W. (2012). Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circulation Research, 110, 1628\u20131645. doi: 10.1161\/CIRCRESAHA.111.259960.Endocardial .","journal-title":"Circulation Research"},{"key":"9612_CR79","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1755-1536-5-7","volume":"5","author":"S Piera-Velazquez","year":"2012","unstructured":"Piera-Velazquez, S., & Jimenez, S. A. (2012). Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases. Fibrogenesis & Tissue Repair, 5, S7. doi: 10.1186\/1755-1536-5-S1-S7 .","journal-title":"Fibrogenesis & Tissue Repair"},{"key":"9612_CR80","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/j.1600-6143.2005.00843.x","volume":"5","author":"A Vongwiwatana","year":"2005","unstructured":"Vongwiwatana, A., Tasanarong, A., Rayner, D. C., et al. (2005). Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. American Journal of Transplantation, 5, 1367\u20131374.","journal-title":"American Journal of Transplantation"},{"key":"9612_CR81","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","volume":"13","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg, E. M., Tarnavski, O., Zeisberg, M., et al. (2007). Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature Medicine, 13, 952\u2013961. doi: 10.1038\/nm1613 .","journal-title":"Nature Medicine"},{"key":"9612_CR82","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1111\/j.1582-4934.2011.01450.x","volume":"15","author":"B Zhou","year":"2011","unstructured":"Zhou, B., & Pu, W. T. (2011). Epicardial epithelial-to-mesenchymal transition in injured heart. Journal of Cellular and Molecular Medicine, 15, 2781\u20132783. doi: 10.1111\/j.1582-4934.2011.01450.x .","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"9612_CR83","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/tmj.2012.0172","volume":"19","author":"S Chen","year":"2013","unstructured":"Chen, S., Cheng, A., & Mehta, K. (2013). A review of telemedicine business models. Telemedicine Journal and E Health, 19, 287\u2013297. doi: 10.1089\/tmj.2012.0172 .","journal-title":"Telemedicine Journal and E Health"},{"key":"9612_CR84","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.healun.2008.11.915","volume":"28","author":"JMDLT Hernandez","year":"2009","unstructured":"Hernandez, J. M. D. L. T., de Prada, J. A. V., Burgos, V., et al. (2009). Virtual histology intravascular ultrasound assessment of cardiac allograft vasculopathy from 1 to 20\u00a0years after heart transplantation. Journal of Heart and Lung Transplantation, 28, 156\u2013162. doi: 10.1016\/j.healun.2008.11.915 .","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"9612_CR85","first-page":"1054","volume":"6","author":"TN Machuca","year":"2014","unstructured":"Machuca, T. N., & Cypel, M. (2014). Ex vivo lung perfusion. Journal Thoracic Diseases, 6, 1054\u20131062. doi: 10.3978\/j.issn. 2072-1439.2014.07.12 .","journal-title":"Journal Thoracic Diseases"},{"key":"9612_CR86","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thorsurg.2014.09.002","volume":"25","author":"M Cypel","year":"2015","unstructured":"Cypel, M., & Keshavjee, S. (2015). Extending the donor pool: rehabilitation of poor organs. Thoracic Surgery Clinics, 25, 27\u201333.","journal-title":"Thoracic Surgery Clinics"},{"key":"9612_CR87","unstructured":"Machuca, T.N., Cypel, M., Yeung, J.C., Bonato, R., Zamel, R., Chen, M., Azad, S, Hsin, M.K., Saito, T., Guan, Z., Waddell, TK., Liu, M.K.S. (2014). Protein Expression Profiling Predicts Graft Performance in Clinical Ex Vivo Lung Perfusion. Ann. Surg."},{"key":"9612_CR88","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.transproceed.2008.08.073","volume":"40","author":"S-S Wang","year":"2008","unstructured":"Wang, S.-S. (2008). Treatment and prophylaxis of cardiac allograft vasculopathy. Transplantation Proceedings, 40, 2609\u20132610.","journal-title":"Transplantation Proceedings"},{"key":"9612_CR89","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/j.healun.2004.03.009","volume":"23","author":"H Valantine","year":"2004","unstructured":"Valantine, H. (2004). Cardiac allograft vasculopathy after heart transplantation: risk factors and management. Journal of Heart and Lung Transplantation, 23, S187\u2013S193.","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"9612_CR90","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1600-6143.2004.00475.x","volume":"4","author":"JA Kobashigawa","year":"2004","unstructured":"Kobashigawa, J. A. (2004). Statins in solid organ transplantation: is there an immunosuppressive effect? American Journal of Transplantation, 4, 1013\u20131018.","journal-title":"American Journal of Transplantation"},{"key":"9612_CR91","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.transproceed.2006.02.071","volume":"38","author":"F Grigioni","year":"2006","unstructured":"Grigioni, F., Carigi, S., Potena, L., et al. (2006). Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. Transplantation Proceedings, 38, 1507\u20131510. doi: 10.1016\/j.transproceed.2006.02.071 .","journal-title":"Transplantation Proceedings"},{"key":"9612_CR92","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1517\/14656566.7.17.2369","volume":"7","author":"J Segovia","year":"2006","unstructured":"Segovia, J., G\u00f3mez-Bueno, M., & Alonso-Pulp\u00f3n, L. (2006). Treatment of allograft vasculopathy in heart transplantation. Expert Opinion on Pharmacotherapy, 7, 2369\u20132383. doi: 10.1517\/14656566.7.17.2369 .","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"9612_CR93","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.trre.2009.01.002","volume":"23","author":"JF Delgado","year":"2009","unstructured":"Delgado, J. F., Manito, N., Segovia, J., et al. (2009). The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation. Transplantation Reviews, 23, 69\u201379.","journal-title":"Transplantation Reviews"},{"key":"9612_CR94","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1600-6143.2006.01282.x","volume":"6","author":"S Kuppahally","year":"2006","unstructured":"Kuppahally, S., Al-Khaldi, A., Weisshaar, D., et al. (2006). Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. American Journal of Transplantation, 6, 986\u2013992. doi: 10.1111\/j.1600-6143.2006.01282.x .","journal-title":"American Journal of Transplantation"},{"key":"9612_CR95","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/ajt.12208","volume":"13","author":"M Masetti","year":"2013","unstructured":"Masetti, M., Potena, L., Nardozza, M., et al. (2013). Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. American Journal of Transplantation, 13, 1207\u20131226. doi: 10.1002\/ajt.12208 .","journal-title":"American Journal of Transplantation"},{"key":"9612_CR96","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","volume":"349","author":"J Kobashigawa","year":"2003","unstructured":"Kobashigawa, J., Mancini, D., S\u00f8rensen, K., et al. (2003). Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. New England Journal of Medicine, 349, 847\u2013858.","journal-title":"New England Journal of Medicine"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-015-9612-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12265-015-9612-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-015-9612-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T05:45:38Z","timestamp":1691041538000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12265-015-9612-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,5]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["9612"],"URL":"https:\/\/doi.org\/10.1007\/s12265-015-9612-x","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,5]]}}}